Cellebration Life Sciences

About:

Cellebration Life Sciences offers research and treatments for autoimmune diseases and orthopedic injuries.

Website: https://cellebrationlifesciences.com

Description:

Cellebration Life Sciences offers and administers stem-cell-based therapies specialized to treat specific degenerative conditions and directly target the area of concern in rejuvenation therapies. Cellebration Life Sciences currently has underway an FDA Clinical Trial application to develop a curative treatment for Type 2 Diabetes. The company is also conducting further research to advance efforts to find permanent curative treatments for arthritis and other autoimmune diseases.

Total Funding Amount:

$2.8M

Headquarters Location:

San Diego, California, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)cellebrationlifesciences.com

Founders:

Anand Srivastava, Bill Deegan, Deven Patel, Siddharth Bhavsar, Timothy Kopatich

Number of Employees:

1-10

Last Funding Date:

2021-06-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai